| Issue Date | Title | Author(s) |
| 2014-01-21 | Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse | Lund, ME; O'Brien, BA; Hutchinson, AT; Robinson, MW; Simpson, AM; Dalton, JP; Donnelly, S |
| 2015-11-01 | Gene therapy for diabetes: reversal of diabetes in the humanised FRG mouse model | Simpson, A; Ren, B; O'Brien, BA; Alexander, IE; Nassif, NT; Tan, Y; Martiniello-Wilks, R |
| 2013-01-01 | Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy | Ren, B; O'Brien, BA; Byrne, MR; Ch'ng, E; Gatt, PN; Swan, MA; Nassif, NT; Wei, MQ; Gijsbers, R; Debyser, Z; Simpson, AM |
| 2016-11-24 | A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis | Lund, ME; Greer, J; Dixit, A; Alvarado, R; McCauley-Winter, P; To, J; Tanaka, A; Hutchinson, AT; Robinson, MW; Simpson, AM; O'Brien, BA; Dalton, JP; Donnelly, S |
| 2015-05-01 | Pancreatic Transdiffereniation of Human Hepatocytes in the Livers of a Humanized Mouse Model | Ren, B; O'Brien, BA; Alexander, IE; Nassif, NT; Tan, Y; Martiniello-Wilks, R; Simpson, AM |
| 1997-05-01 | Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse | O'Brien, BA; Harmon, BV; Cameron, DP; Allan, DJ |
| 2008-01-01 | Growth-promoting effect of Rh(D) antibody on human pancreatic islet cells | Feller, JM; Simpson, AM; Nelson, M; Swan, MA; O'Connell, PJ; Hawthorne, WJ; Tao, C; O'Brien, BA |
| 2013-08-01 | REVERSAL OF DIABETES IN A PORCINE MODEL FOLLOWING LIVER-DIRECTED GENE THERAPY | Gerace, D; Ren, B; Hawthorne, WJ; Byrne, MR; Phillips, P; O'Brien, BA; Nassif, N; Alexander, IE; Simpson, AM |
| 2015-06-06 | Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: Systematic review and meta-analysis | Archer, NS; Nassif, NT; O'Brien, BA |
| 2022-07-08 | Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment. | Mahoney, ALG; Nassif, NT; O'Brien, BA; Simpson, AM |
